KMID : 0384020070180010051
|
|
Journal of the Korean Society of Logopedics and Phoniatrics 2007 Volume.18 No. 1 p.51 ~ p.55
|
|
Efficacy of Fozen Reconstituted Botulinum Toxin Type A for the Treatment of Spasmodic Dysphonia
|
|
Park Shin-Hong
So Yoon-Kyoung Jeong Han-Sin Son Young-Ik
|
|
Abstract
|
|
|
Objectives: The aim of this study is to compare the efficacy of fresh versus frozen reconstituted botulinum toxin type A (BTX-A) for the treatment of adductor type spasmodic dysphonia.
Materials and Methods: After reconstitution with normal saline, BTX-A was used within 4 hours or it was kept frozen in a consumer grade freezer at about -25?C for up to 4 months. Thirty patients with spasmodic dysphonia were randomly assigned and treated with the either fresh or frozen BTX-A. About 83% of injections resulted in a satisfactory outcome with 5.3 months of mean action duration. Treatment outcomes and side effects of total 161 injections were compared along the duration of keeping BTX-A frozen.
Results: There were no statistical differences in the duration of action, self-rated satisfaction score, and the duration of hoarseness and/or aspiration between fresh and frozen BTX-A treated groups. No significant side effects were observed and the frozen BTX-A were proved to be free of bacterial contamination.
Conclusion: After being reconstituted and kept frozen, BTX-A may be safely used for more than 4 months without significant loss of its effectiveness or additional side effects.
|
|
KEYWORD
|
|
Spastic dysphonia, Botulium toxin type A, Drug storage, Freezing
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|